Other Clinical Trial - Cognitive Rehabilitation in Post-COVID-19 Syndrome

Status Recruiting

Clinical Trial Summary

The first aim of this study is to determine the feasibility of delivering CO-OP remotely to individuals experiencing cognitive impairments that limit everyday activities in post-COVID-19 syndrome (PCS). The second aim of this study is to assess the effect of CO-OP on activity performance, subjective and objective cognition, and quality of life in a sample of individuals with PCS. The research team hypothesizes that effect size estimations will indicate that CO-OP will have a greater positive effect, compared to an inactive control group, on activity performance, subjective and objective cognition, and quality of life in a sample of individuals who self-report PCS and cognitive impairment.

Clinical Trial Description

Post-COVID-19 symptoms (PCS) cognitive symptoms require the rehabilitation community to investigate ways to: (1) reduce the functional impact of the symptoms on daily life and (2) support individuals with PCS to establish new habits to improve and maintain health. While the cognitive impairment associated with PCS has not been well evaluated, it is similar of cognitive symptoms seen in other conditions. Metacognitive strategy training (MCST) approaches are an evidence-based practice standard for improving capacity to self-manage chronic cognitive symptoms and reduce their functional impact on everyday life activities. The CO-OP approach is an MCST intervention in which participants are taught a general cognitive strategy that can be applied in known and novel contexts to devise task specific strategies for engaging in an activity. Existing evidence with other populations suggests that CO-OP has more of a positive effect on improving activity performance and cognition than remediation/retraining-based approaches. These effects have been demonstrated in individuals with mild cognitive impairment that mirrors that found in PCS. The overall research hypothesis is that CO-OP can feasibly be administered remotely and will improve activity performance, subjective and objective cognitive function, and quality of life in individuals with PCS. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06136871
Study type	Interventional
Source	University of Missouri-Columbia
Contact	Anna E Boone, PhD, OTR/L
Phone	573-882-7023
Email	booneae@umsystem.edu
Status	Recruiting
Phase	N/A
Start date	January 29, 2024
Completion date	December 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06073002` - Effects of a Home-Based Exercise Intervention in Subjects With Long COVID	N/A
Completed	`NCT05047952` - Vortioxetine for Post-COVID-19 Condition	Phase 2
Completed	`NCT05812209` - Stellate Ganglion Block to Treat Long COVID 19 Case Series
Recruiting	`NCT06091384` - Inspiratory Muscle Strength Training in Post-Covid Syndrome	N/A
Not yet recruiting	`NCT06267300` - Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial	Phase 3
Recruiting	`NCT05986422` - Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS)	Phase 2
Not yet recruiting	`NCT05534997` - Rehabilitation Therapy for Post COVID 19 Chronic Fatigue Syndrome	N/A
Recruiting	`NCT05638633` - Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome	Phase 3
Active, not recruiting	`NCT05630040` - VNS for Long-COVID-19	N/A
Recruiting	`NCT05841498` - Immunoadsorption Study Mainz in Adults With Post-COVID Syndrome	N/A
Enrolling by invitation	`NCT05981872` - EFFECT OF COGNITIVE BEHAVIORAL THERAPY ON DEPRESSION AND QUALITY OF LIFE IN PATIENTS WITH POST COVID-19	N/A
Active, not recruiting	`NCT05543408` - Long COVID-19 Syndrome in Primary Care: A Novel Protocol of Exercise Intervention "CON-VIDA Clinical Trial"	N/A
Recruiting	`NCT05817032` - Effect of Telerehabilitation Practice in Long COVID-19 Patients	N/A
Recruiting	`NCT05823896` - imPROving Quality of LIFe In the Long COVID Patient	Phase 2
Completed	`NCT05764070` - Impact of Vagus Nerve Stimulation on Post-Aerobic Activity Recovery in Post SARS-CoV-2 Patients	N/A
Completed	`NCT05765591` - Balneotherapy for Patients With Post-acute Coronavirus Disease (COVID) Syndrome	N/A
Recruiting	`NCT05918965` - Vagus Stimulation in Female Long COVID Patients.	N/A
Not yet recruiting	`NCT06231238` - Balance Acceptance and Commitment Therapy for Long COVID	Phase 2
Completed	`NCT06282627` - The COVID HOME Study: Prospective Cohort Study of Non-hospitalised COVID-19 Patients
Completed	`NCT05648734` - Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.